Citing COVID-19, USTR Extends Tariff Exclusions For Some Medical Products

By INSIDE US TRADE / December 31, 2020 at 10:17 AM
The Office of the U.S. Trade Representative has extended exclusions from Section 301 tariffs for some medical products to “address COVID-19,” it said in a notice issued on Dec. 29. The exclusions were set to expire Dec. 31. They will be extended through March 31, the notice states. Guidance on the tariff exclusions will be issued by U.S. Customs and Border Protection. Throughout the process of evaluating requests for product exclusions submitted since the president imposed the Section 301 tariffs...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.